Cause Of Death In Adults Research Articles

5.X.1. Co-designing for policy impact: Belgium’s monitoring & evaluation framework for cancer care & control

Abstract Cancer is one of the main public health challenges, and the second leading cause of mortality in the EU. It is Belgium’s second leading cause of adult death after circulatory diseases and has been an increasing burden of disease in recent years. Recognizing the urgency of tackling the entire disease pathway, the European Commission (EC) has launched Europe’s Beating Cancer Plan (EBCP), a policy-driven strategy, and the Mission on Cancer, a research-focused undertaking. In Belgium, Sciensano’s Cancer Centre has been charged with the coordination and implementation of these programs, pioneering the setup of a dedicated structure to coordinate them. While Belgian public, academic, private and non-for-profit entities have been highly involved in these EU initiatives since their launch, there is currently no mechanism to monitor the impact of EBCP’s uptake and implementation in Belgium. Moreover, in contrast to the investment and momentum at the European level, the last Belgian Cancer Plan dates from 2008, with its most recent evaluation being published in 2013, highlighting an important gap. To address this gap, the Cancer Centre was asked by the Federal Cabinet to develop a new monitoring and evaluation (M&E) framework for cancer care and control in Belgium. With a view to avoiding traditional top-down approaches, it was decided that the framework would be designed co-creatively, by engaging patients and experts in the field. The aim was to enable the iterative and flexible monitoring of Belgian policies related to the EBCP’s implementation, while generating buy-in from stakeholders. To achieve this goal, a modified Delphi process was used, with complementary qualitative data collection in the form of focus group discussions with experts across the cancer continuum. A Steering and Patient Committee were put in place to provide stewardship over the process, and based on their feedback, additional patient workshops were run to ensure M&E priorities for patients were taken into account. The framework will cover the entire spectrum of cancer prevention and control, as well as transversal themes such as inequalities and patient-centeredness. It will also anticipate future evolutions and undergo adjustments when needed. This workshop will use a Pecha Kucha approach, with panelists sharing insights from the Belgian case study. The session will guide the audience through a story of the strengths and pitfalls of co-creating an M&E framework in the field of public health monitoring. Topics covered will include challenges of monitoring cancer care and control policies, approaches taken in Belgium to overcome these challenges, and the importance of involving diverse stakeholders in the process. A moderated discussion will allow participants to share their perspectives and ask questions. Attendees will walk away with a real-world example on how to challenge top-down paradigms of population-level M&E frameworks and identify transferable elements for adaptation in their own settings. Key messages • Europe’s Beating Cancer Plan (EBCP) provides opportunities to tackle the second leading cause of disease in the EU but will require innovative approaches to monitor uptake and impact. • Development of Belgium policy-actionable monitoring & evaluation framework shows how co-creation can challenge top-down paradigms in public health monitoring and assess the uptake and impact of EBCP. Speakers/Panelists Gabrielle Schittecatte Sciensano, Brussels, Belgium Jinane Ghattas Sciensano, Brussels, Belgium Robbe Saesen Sciensano, Maaseik, Belgium

An Extensive Analysis of Liver Cirrhosis’s Genesis, Pathophysiology, Epidemiology, And Diagnosis

Portal hypertension and liver failure can arise as a result of liver cirrhosis, a chronic illness characterized by the fibrosis and renewal of nodules in the liver. A number of long-term conditions can lead to cirrhosis, a progressive disease. after a few years or perhaps decades. Liver cirrhosis is one public health concern. Metabolic syndrome, autoimmune diseases, storage diseases, drug use, alcohol consumption, viral hepatitis, and toxic chemicals are the usual causes. Cirrhosis is the fourteenth most prevalent cause of death in adults. placing ninth overall and fourth in Europe and the US. Because this condition is symptomatic and often remains undiagnosed in its early stages, its frequency is underestimated. It typically progresses to the decompensated stage at a rate of 5 to 7% annually. Here, we discuss the pathophysiology, epidemiology, diagnosis, and etiology of liver cirrhosis.

Abstract P415: The Current Cardiac Disease in Pregnancy -II Risk Score as a Predictor of Pregnancy Morbidity is Not Affected by Maternal Obesity

Cardiovascular disease (CVD) is the most common cause of death in adults over 40 years of age. CVD remains a common cause of death in pregnancy and within the first-year post-partum, and Black women have higher cardiovascular risk during pregnancy than White women. There are several established mortality and morbidity prediction models for maternal cardiac complications including the Cardiac Disease in Pregnancy (CARPREG) risk score. CARPREG-II is the newest risk score which uses ten criteria to predict maternal cardiac complications. However, the only study to validate the CARPREG-II risk score had a large sample size with only 15% of patients with obesity (body mass index (BMI) >30 kg/m2). Obesity and increased obesity class are known risks factors for pregnancy related morbidity and mortality. Thus, the validity of CARPREG-II risk score as a predictor of cardiovascular risks and pregnancy outcomes in women with cardiac disease and obesity remains unknown. Therefore, the goals of our study were to assess the validity of the CARPREG-II score in Black and White women as a predictor of risk for cardiovascular morbidity and mortality in obese pregnant women and determine if obesity influences CARPREG-II score and pregnancy morbidity and mortality. For this study, we completed an IRB-approved retrospective chart review of 232 pregnant adult Black and White women who received care at the University of Mississippi Medical Center (UMMC) from January 2013 - 2020. We completed a CARPREG-II risk score and compared morbidity in patients with normal BMI (18-24.9 kg/m2), overweight (25-29.9 kg/m2), obesity class I (30-34.9 kg/m2), obesity class II (35-39.9 kg/m2), and obesity class III (>40 kg/m2). By race, the majority of White women were categorized as overweight; whereas the majority of Black women were categorized as obesity class II or III (p=0.0016). Although frequency of BMI category differed by race, CARPREG-II score did not differ as BMI increased in Black or White women, and obesity class did not influence CARPREG-II risk score. Our data indicate that Black women were more likely to have increased obesity, but obesity class did not influence CARPREG-II score. The lack of association between obesity class and CARPREG-II risk score indicate that the current CARPREG-II assessment is not an appropriate risk assessment tool for pregnant obese women and additional studies/tools are warranted to determine cardiovascular risks in pregnant obese women.

A cognitive-behavioral treatment for suicide prevention among adults with schizophrenia spectrum disorders in community mental health: Study protocol for a pilot feasibility and acceptability randomized clinical trial

BackgroundSuicide is among the leading causes of death for adults with schizophrenia spectrum disorders (SSDs), and there is a paucity of evidence-based suicide prevention-focused interventions tailored for this vulnerable population. Cognitive-Behavioral Suicide Prevention for psychosis (CBSPp) is a promising intervention developed in the UK that required modifications for delivery in community mental health (CMH) settings in the United States of American. This pilot trial evaluates the feasibility, acceptability, and preliminary effectiveness of our modified CBSPp intervention in comparison to services as usual (SAU) within a CMH setting in a Midwestern state of the USA.MethodsThis is a single-site randomized pilot trial with a planned enrollment of 60 adults meeting criteria for both SSD and SI/A. Eligible participants will be randomized 1:1 to either 10 sessions of CBSPp or SAU. Clinical and cognitive assessments will be conducted within a 4-waive design at baseline (prior to randomization and treatment) and approximately 1 month (mid-treatment), 3 months (post-treatment), and 5 months (follow-up) after baseline assessment. Qualitative interviews will also be conducted at post-treatment. The primary objective is to determine whether CBSPp is feasible and acceptable, involving examinations of recruitment rate, treatment engagement and adherence, retention and completion rates, and experiences in the CBSPp treatment and overall study. The secondary objective is to preliminarily evaluate whether modified CBSPp is associated with reductions in clinical (suicide ideation, suicide attempt, symptoms of psychosis, depression, and emergency/hospital service, hopelessness, defeat, and entrapment) and cognitive (information processing biases, appraisals, and schemas) outcomes in comparison to SAU from baseline to post-treatment assessment.DiscussionThis randomized pilot trial will provide clinically relevant information about whether CBSPp can improve SI/A, depression, and psychosis among adults with SSDs. Testing this modified cognitive-behavioral suicide prevention-focused intervention has the potential for a large public health impact by increasing the intervention’s utility and usability in CMH where many individuals with SSDs receive care, and ultimately working towards reductions in premature suicide death.Trial registrationClinicalTrials.gov NCT#05345184. Registered on April 12, 2022.

NanoGraphene Clot: A New Fibrinogen-Mimic Hemostatic Material.

Trauma is the leading cause of death for adults under the age of 44. Internal bleeding remains a significant challenge in medical emergencies, necessitating the development of effective hemostatic materials that could be administered by paramedics before a patient is in the hospital and treated by surgeons. In this study, we introduce a graphene oxide (GO)-based PEGylated synthetic hemostatic nanomaterial with an average size of 211 ± 83 nm designed to target internal bleeding by mimicking the role of fibrinogen. Functionalization of GO-g-PEG with peptides derived from the α-chain of fibrinogen, such as GRGDS, or the γ-chain of fibrinogen, such as HHLGGAKQAGDV:H12, was achieved with peptide loadings of 72 ± 6 and 68 ± 15 μM, respectively. In vitro studies with platelet-rich plasma (PRP) under confinement demonstrated aggregation enhancement of 39 and 24% for GO-g-PEG-GRGDS and GO-g-PEG-H12, respectively, compared to buffer, while adenosine diphosphate (ADP) alone induced a 5% aggregation. Compared to the same materials in the absence of ADP, GO-g-PEG-GRGDS achieved a 47% aggregation enhancement, while GO-g-PEG-H12 a 25% enhancement. This is particularly important for injectable hemostats and highlights the fact that our nanographene-based materials can only act as hemostats in the presence of agonists, reducing the possibility of unwanted clotting during circulation. Further studies on collagen-coated wells under dynamic flow revealed statistically significant augmentation of PRP fluorescence signal using GRGDS- or H12-coated GO-g-PEG compared to controls. Hemolysis studies showed <1% lysis of red blood cells (RBCs) at the highest PEGylated nanographene concentration. Finally, whole human blood coagulation studies reveal faster and more pronounced clotting using our nanohemostats vs PBS control from 3 min and below (blood is clotted with 10% CaCl2 within 4-5 min), with the biggest differences to be shown at 2 and 1 min. At 1 min, the clot weight was found to be ∼45% of that between 4 and 5 min, while no clot was formed in PBS-treated blood. Reduction of CaCl2 to 5 and 3%, or utilization of prostaglandin E1, an anticoagulant, still leads to clots but of smaller weight. The findings highlight the potential of our fibrinogen-mimic PEGylated nanographene as a promising non-hemolytic injectable scaffold for targeting internal bleeding, offering insights into its platelet aggregation capabilities under confinement and under dynamic flow as well as its pronounced coagulation abilities.

Efficacy of cartridge-based nucleic acid amplification test (CBNAAT) in comparison with line probe assay and liquid culture in the evaluation of tubercular lymph node abscess.

Tuberculosis (TB) remains the number one cause of adult deaths by a curable infectious disease. Mycobacterium tuberculosis bacilli (MTB) is the most common causative organism isolated from mycobacterial lymphadenitis. Accurate and speedy diagnosis is required, especially in paucibacillary extrapulmonary TB. In this study, we compared the efficacy of CBNAAT with line probe assay and liquid culture in the evaluation of tubercular lymph node abscesses. This is a hospital-based observational cross-sectional study conducted at Gandhi Medical College and Hospital, Secunderabad, TS, in patients who presented with lymph node abscesses over a period of 18 months after obtaining clearance from the ethics committee and obtaining informed consent. Each sample was evaluated and analyzed in association with the clinical findings, AFB staining, CBNAAT, LPA, and AFB culture, and the results were compared. Fifty patients with TB lymph node abscess diagnosed through FNAC were included in the present study. AFB smear was positive in 29 samples, CBNAAT was positive in 43 samples, LPA was positive in 44 samples, and liquid culture was positive in 39 samples. CBNAAT could detect TB in 16 smear-negative cases, 10 liquid culture-negative cases, and one LPA-negative case. In our study, CBNAAT was more effective in diagnosing TB lymph node abscess than AFB smear. No significant results were obtained when comparing CBNAAT with LPA and liquid culture. This study demonstrates excellent diagnostic accuracy of the Xpert MTB/RIF test in patients with tuberculous lymphadenitis, with a sensitivity of 86%, specificity of 83.33%, negative predictive value of 95.56%, and positive predictive value of 58.82%. Thus, it can be a rule in testing for lymph node TB. These efforts will contribute to the attainment of the TB elimination goal.

Estimation of cause-specific mortality in Rakai, Uganda, using verbal autopsy 1999-2019

ABSTRACT Background There are scant data on the causes of adult deaths in sub-Saharan Africa. We estimated the level and trends in adult mortality, overall and by different causes, in rural Rakai, Uganda, by age, sex, and HIV status. Objectives To estimate and analyse adult cause-specific mortality trends in Rakai, Uganda. Methodology Mortality information by cause, age, sex, and HIV status was recorded in the Rakai Community Cohort study using verbal autopsy interviews, HIV serosurveys, and residency data. We estimated the average number of years lived in adulthood. Using demographic decomposition methods, we estimated the contribution of each cause of death to adult mortality based on the average number of years lived in adulthood. Results Between 1999 and 2019, 63082 adults (15–60 years) were censused, with 1670 deaths registered. Of these, 1656 (99.2%) had completed cause of death data from verbal autopsy. The crude adult death rate was 5.60 (95% confidence interval (CI): 5.33–5.87) per 1000 person-years of observation (pyo). The crude death rate decreased from 11.41 (95% CI: 10.61–12.28) to 3.27 (95% CI: 2.89–3.68) per 1000 pyo between 1999–2004 and 2015–2019. The average number of years lived in adulthood increased in people living with HIV and decreased in HIV-negative individuals between 2000 and 2019. Communicable diseases, primarily HIV and Malaria, had the biggest decreases, which improved the average number of years lived by approximately extra 12 years of life in females and 6 years in males. There were increases in deaths due to non-communicable diseases and external causes, which reduced the average number of years lived in adulthood by 2.0 years and 1.5 years in females and males, respectively. Conclusion There has been a significant decline in overall mortality from 1999 to 2019, with the greatest decline seen in people living with HIV since the availability of antiretroviral therapy in 2004. By 2020, the predominant causes of death among females were non-communicable diseases, with external causes of death dominating in males.

Initial experience of endovascular aneurysm repair at the Dr. Eduardo Liceaga General Hospital of Mexico

Background: Abdominal aortic aneurysm (AAA) is the permanent and irreversible dilation of the lower part of the aorta where the vessel expands, making it susceptible to rupture, which represents a high mortality incident. Methods: A review of clinical records was carried out from September 2021 to March 2023, patients who were diagnosed with aortic aneurysm were included in whom endovascular exclusion of abdominal and thoracic aortic aneurysm was performed at the General Hospital of Mexico by the angiology vascular and endovascular surgery department. Results: 18 endovascular repairs of aortic aneurysms were performed, of which 15.4% were female (n=6) and 84.6% male (n=12). The average proximal neck diameter in the thoracic aorta was 31 mm, average proximal neck diameter in infrarenal AAA 22.2 mm, average aneurysmal diameter in infrarenal segment 63.8 mm, thoracic 31 mm. Regarding the type of endovascular procedure, 11.1% were repaired with the fenestrated endovascular aneurysm repair (FEVAR) technique, and the same proportion with chimney endovascular aneurysm repair (ChEVAR), for a resolution with conventional EVAR of 77.7%. Complications occurred in 3 patients, 2 of which resulted in type 1a and 1b endoleaks that were reoperated and repaired with a proximal cuff, balloon angioplasty, and embolization of the aneurysmal sac with coils. Conclusions: Aortic aneurysm remains a major cause of death in adults because of aortic rupture despite advances over the past two decades that have been made in the endovascular management of large, symptomatic, and ruptured. Timely treatment is essential to prevent rupture and poor patient outcomes.

Abstract 6211: Clinical and prognostic assessment of the lncRNA ZFAS1-related gene signature in colorectal cancer

Abstract Colorectal cancer (CRC) is one of the leading causes of cancer death with a rapidly rising incidence rate in younger adults. It is projected to be the leading cause of death in adults under 50 years old by 2030. Although progress over the last couple of decades has improved the clinical management of patients affected by CRC, there is a lack of accurate biomarkers to stratify CRC patients. Among several other biomolecules, lncRNAs (long non-coding RNAs) are non-coding transcripts under 200 nucleotides that can regulate gene expression. Furthermore, lncRNAs are important players in oncogenesis and cancer progression and have the potential to be used as reliable biomarkers. Through this study, we explored the clinical relevance of lncRNAs in colorectal cancer. To analyze the distribution of lncRNAs, we utilized de-identified FFPE (formalin-fixed paraffin-embedded) blocks from Augusta University (n = 88). FFPE blocks were sectioned to extract tissue segments and were subsequently stained using H&amp;E (hematoxylin and eosin dyes) to identify the tumor and adjacent normal regions. The quantification of the gene expression was performed using a medium-throughput NanoString platform. Further analyses were performed using clinicopathological features of the institutional cohort and an independent Cancer Genome Atlas (TCGA) dataset. TCGA contains genomic data along with clinical and molecular characterization of over 11,000 samples of various lineages. In the institutional cohort, ZFAS1 showed higher gene expression in the low survival group for stage II and III colorectal cancer patients, while no significant difference was observed in stage I and IV patients. ZFAS1 expression did not significantly correlate with other clinicopathological parameters, including race, alcohol consumption, tobacco consumption, age, grade, and family history of cancer. In an orthogonal TCGA analysis, higher ZFAS1 expression was associated with genomic perturbations, including significantly altered tumor mutational burden (TMB), aneuploidy, fractional genome alteration, and microsatellite instability. Further, a 21-gene signature was developed for prognostication using gene co-expression network analysis. The gene signature was significantly associated with overall and disease-free survival in the TCGA-CRC cohort. Immune deconvolution analysis of the RNA sequencing data revealed that higher expression of the 21-gene signature was associated with increased infiltration of regulatory T cells while being inversely correlated with the overall level of T cells. In conclusion, our study identified the clinicopathological role of ZFAS1 lncRNA and its interaction genes with prognostic significance in colorectal cancer. Further investigation into the therapeutic relevance of the ZFAS1-related gene signature may prove invaluable in improving the clinical outcomes of colorectal cancer patients. Citation Format: Pankaj Kumar Ahluwalia, Tiffanie Leeman, Ashis Mondal, Ashutosh Vashisht, Harmanpreet Singh, Nivin Omar, Kimya Jones, Ravindra Kolhe. Clinical and prognostic assessment of the lncRNA ZFAS1-related gene signature in colorectal cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 6211.

Presenting an Intelligent Algorithm to Predict Heart Attack

Introduction: Today, heart attack is one of the most common causes of death in adults all over the world. According to the announcement of the Ministry of Health, Treatment, and Medical Education, 11 to 15 percent of deaths in Iran are caused by heart attacks, and in the world, Iran has the highest number of deaths due to heart disease in 2022. It has been estimated that deaths from these diseases will increase to 20 million people. Therefore, predicting this disease is one of the most challenging topics in the medical field, and today most prediction systems are created using artificial intelligence and machine learning algorithms. Method: This applied and descriptive research was conducted in 2022 using the information of 600 people who referred to Peymaniyeh and Motahari hospitals in Jahrom city. In this research, data were collected based on the available sources from both hospitals. To implement and evaluate the results, MATLAB programming language was used. Results: The parameters used in this research are among the classification parameters, including classification rate, precision, recall, and F -measure, which were obtained as 90.7, 90.2, 91.5, and 90.8, respectively. Conclusion: The results show that the proposed model will be able to predict the probability of stroke with a high percentage.

Strategies to prevent or reduce inequalities in specific avoidable causes of death for adults with intellectual disability: A systematic review

AbstractBackgroundWe now have sufficient evidence demonstrating inequalities in specific avoidable causes of death for adults with intellectual disability compared to their peers without intellectual disability. Apart from covid‐19, the largest differentials that disadvantage people with intellectual disability are in relation to pneumonia, aspiration pneumonia, epilepsy, cerebrovascular disease, ischaemic heart disease, deep vein thrombosis, diabetes and sepsis. The aim of this systematic review is to report on strategies at the individual, population or policy levels aimed at preventing these conditions that are applicable to adults with intellectual disability and that have been based on or recommended by research.MethodsSystematic review of PUBMED, EMBASE, CINAHL, PsychInfo, Social Care Online, International Bibliography of the Social Sciences (IBSS), Web of Science, Scopus, Overton, the Cochrane Library and Google Scholar databases was carried out. Searches were completed on 30 June 2023. Quantitative, qualitative and mixed‐methods research; systematic, scoping or evidence‐based reviews; and audit and reports of mortality reviews were included. Publications included in the review were about preventing the eight potentially avoidable causes of death.FindingsNinety‐four papers were included in the review (9 in relation to pneumonia; 11 for aspiration pneumonia; 18 for sudden unexpected death in epilepsy; 7 for cerebrovascular disease; 8 for ischaemic heart disease; 4 for deep vein thrombosis; 31 for diabetes; 6 for sepsis). The eight most frequently occurring potentially avoidable causes of death in people with intellectual disability are very different medical conditions, but they shared striking similarities in how they could be prevented. The literature overwhelmingly implicated the need to make lifestyle changes to address obesity, lack of exercise and poor nutrition, and to have regular medical reviews. In addition, ‘whole‐population’ approaches are required that look beyond the individual to the social determinants of health.ConclusionsWe found little peer‐reviewed evidence specifically about preventing these conditions in people with intellectual disability. However, most of the literature about preventative strategies pertaining to the general population was applicable to people with intellectual disability, albeit that some ‘reasonable adjustments’ would be required.

Baseline absolute monocyte count predicts lung function decline among patients with systemic sclerosis-associated interstitial lung disease: A post hoc analysis from the focuSSced trial

ObjectiveInterstitial lung disease (ILD) is the leading cause of death in adults with systemic sclerosis (SSc). The identification of biomarkers to predict progression of SSc-ILD is an important unmet need. The purpose of this study was to determine whether an elevated baseline absolute monocyte count (AMC) is associated with a decline in forced vital capacity (FVC) at 48 weeks among participants with SSc-ILD enrolled in the phase 3 focuSSced trial. MethodsWe performed a post-hoc analysis of the focuSSced trial, a multicenter, double-blind, randomized, placebo-controlled trial of adults with diffuse cutaneous SSc for ≤ 60 months. Participants received subcutaneous tocilizumab 162 mg or placebo weekly for 48 weeks. We examined the relationship between baseline AMC and FVC at 48 weeks using a General Linear Model adjusted for potential confounders. ResultsThe 136 participants with SSc-ILD in focuSSced were included in this study. Among participants assigned to the placebo group, there was a statistically significant inverse association between baseline AMC and change in FVC from baseline at week 48 in both unadjusted (β coefficient -0.539, 95 % CI -1.032 to -0.047, p-value=0.032) and multivariable-adjusted (β coefficient -0.573, 95 % CI -1.086 to -0.060, p-value=0.029) models. Among participants with SSc-ILD assigned to the tocilizumab group, there was no statistically significant association between baseline AMC and change in FVC from baseline at week 48 in unadjusted or fully adjusted models. ConclusionAMC may be a biomarker of disease progression in SSc-ILD, especially in those with early SSc with elevated circulating inflammatory markers. These results should be validated in other SSc-ILD cohorts.

Fatal bleeding following scalp laceration: an uncommon cause of death in adults

ABSTRACT Any wound of the scalp involving the subcutaneous layer may cause profuse bleeding. In such cases, haemorrhage may continue for a while because the natural tension of the scalp inhibits effective haemostasis. In addition, if special conditions coexist, this bleeding may lead to death. We described three cases of haemorrhagic shock by scalp lacerations. An 83-year-old man was found dead in his home lying on a large amount of blood on the floor. He had plenty of comorbidities and a multi-drug therapy, as anticoagulant. A 53-year-old heavy drinker man was found dead in his home with the bathroom and bedroom extensively smeared with blood. A 55-year-old woman with multiple sclerosis was hit in the face by a large stone while she was sitting on her car seat. A toxicological exam on blood revealed benzodiazepines at therapeutic levels. The most relevant conditions that must be present for a scalp laceration to become fatal are unwitnessed head trauma, delayed activation of emergency services, old age, comorbidities, anticoagulant medication, alcohol abuse and significant blood loss from the scalp wound. Other possible causes of death should be excluded. Furthermore, in such cases, the differentiation between homicide and accident can be challenging.

Novel hybrids of 6-amino-3-n-butylphthalide and neuroprotective groups against ischemic stroke

Ischemic stroke (IS) is the leading cause of disability and the second most common cause of death in adults globally.

Survival and causes of death in adults with spina bifida in Sweden: a population-based case-control study.

To analyse survival rates and causes of death in adults with spina bifida in Sweden compared with a matched control group. This population-based study included 11,900 adults born between 1950 and 1997. Three national Swedish registers were used to identify individuals with a diagnosis of spina bifida and a matched control group without spina bifida in the period 1990-2015. International Classification of Diseases codes were used to identify causes of death. Survival analysis was conducted and causes of death in the 2 groups were compared. There was a lower probability of survival for people with spina bifida in all age groups (p < 0.001) compared with the control group. The most prevalent causes of death in people with spina bifida were congenital, respiratory, nervous, cardiovascular, genitourinary, and injuries. People with spina bifida had a higher probability of dying from congenital (p < 0.001), respiratory (p = 0.002), genitourinary (p < 0.002), and nervous-related (p < 0.001) and lower probability of injury-related deaths (p < 0.001). Adults with spina bifida in Sweden have a lower survival rate compared with the general population, with the frequency of certain causes of death differing between the two groups. In order to reduce excess premature mortality, prevention and careful management of potentially fatal conditions are essential throughout a patient's lifespan.

Abstract 429: The Association Between Naloxone Administration and Outcomes for Out-of-Hospital Cardiac Arrest Due to Suspected Overdose

Background: Opioid overdose is increasingly implicated in the development of out-of-hospital cardiac arrest (OHCA) and is a leading cause of death for adults 25 to 64 years old. Aim: Evaluate the association between naloxone use and outcomes after OHCA due to suspected overdose. Methods: This study was a secondary analysis of data collected in the Portland Cardiac Arrest Epidemiologic Registry, a database containing details of Emergency Medical Services (EMS)-treated cases of cardiac arrest around Portland, OR. Eligible patients had non-traumatic OHCA due to presumed overdose with naloxone (exposed) or without naloxone administration (control). We excluded patients with return of spontaneous circulation (ROSC) before the first dose of naloxone. The primary outcome was ROSC at emergency department (ED) arrival. Secondary outcomes included survival to admission; survival to hospital discharge; and cerebral perfusion category score ≤2 at discharge (functional survival). We performed multivariable logistic regressions adjusting for age, sex, arrest location, witness status, bystander interventions, initial EMS rhythm, time from 911 call to EMS arrival, and year of arrest. We separately assessed the subgroup with non-shockable initial rhythms. Results: Of 3,942 OHCA from 2018-2021, EMS documented an overdose etiology in 249. Of these, 236 (94.8%) had all variables and 18 were excluded for achieving ROSC prior to naloxone, resulting in 218 cases for analysis (171 receiving naloxone). Patients receiving naloxone had no difference in adjusted odds (aOR [95% CI]) of ROSC at ED arrival (1.43 [0.64-3.20]), survival to admission (1.87 [0.85-4.10]), survival to discharge (1.99 [0.39-10.30]) and functional survival (1.99 [0.34-11.55]). The subgroup with non-shockable rhythms showed higher odds of survival to admission (2.55 [1.09-5.92]) but not ROSC at ED arrival (1.60 [0.68-3.75]), survival to discharge (8.43 [0.84-84.20]), or good neurologic outcomes (7.26 [0.75-70.42]). Conclusions: For OHCA due to suspected overdose, those with initial non-shockable rhythms who received naloxone had higher adjusted odds of survival to admission than those who did not. Larger studies are necessary to evaluate the impact of naloxone on OHCA outcomes.

Risk of post-fracture pneumonia and its association with cardiovascular events and mortality in adults with intellectual disabilities.

Fragility fractures are associated with an increased risk of pneumonia, which is a leading cause of death in adults with intellectual disabilities; however, the timing and complications of post-fracture pneumonia are underinvestigated. The objectives of this study were to determine the 30-day pneumonia rate post-fracture and the association of post-fracture pneumonia with mortality and cardiovascular events among adults with intellectual disabilities. This retrospective cohort study was conducted using Medicare and commercial claims from 01 January 2011 to 31 December 2016. Incidence of pneumonia 30 days after a fragility fracture among adults ≥18 years old with intellectual disabilities (Fx cohort) was compared to the incidence among matched adults with intellectual disabilities without fractures (w/oFx cohort) and the general population of patients with an incident fragility fracture (GP+Fx). For the Fx cohort, Cox regression was used to examine the adjusted association of time-varying pneumonia (within 30 days post-fracture) with mortality and incidence of cardiovascular events 0-30, 31-365, and 366-730 days post-fracture. There was a high-early rate of pneumonia within 30 days post-fracture for young, middle-aged, and elderly adults with intellectual disabilities (n = 6,183); this rate was 2.2- to 6.1-fold higher than the rate among the w/oFx (n = 12,366) and GP+Fx (n = 363,995) cohorts (all P < 0.05). For the Fx cohort, post-fracture 30-day incidence of pneumonia was associated with an increased 30-day rate of mortality (adjusted HR [aHR] = 5.19; 95% confidence interval [CI] = 3.68-7.32), heart failure (aHR = 2.96; 95% CI = 1.92-4.56), and cerebrovascular disease (aHF = 1.48; 95% CI = 0.93-2.35; P = 0.098), with sustained effects to 1 year for heart failure (aHR = 1.61; 95% CI = 1.19-2.17) and 2 years for mortality (aHR = 1.39; 95% CI = 1.06-1.83), and without evidence of effect modification by age. Adults with intellectual disabilities are vulnerable to post-fracture pneumonia within 30 days, and complications arising from this, across the adult lifespan, and not only during the elderly years.

Pharmacognostical and phytochemical analysis of 10% aqueous extract of leaves of shigru (Moringa oleifera lam.), along with its in vitro comparative study in different cell lines of oral cancer

Most common and fast spreading disease in the present era is CANCER. Oral cancer ranks in the top three of all cancers in India, which account for over 30 % of all cancer reported in the country. Cancers are the most common cause of death in adults. Oral cancer is any malignant neoplasm which is found in oral cavity. The incidence of oral cancer is highest in India, South and Southeast Asian countries. In India, 90-95% of the oral cancers are squamous cell carcinoma. Cancer is really having a limited line of treatment and its prognosis; the fate is also unpredictable. It could be said that this is the disease of modernisation. But since it is not true as such incurable tumours like Raktarbuda and Mansarbuda have been described around 1500 B.C. by Acharya Charaka and Ayurvedic surgeon Acharya Sushruta. Nowadays research is going to invent an Ayurvedic medicine to prevent or to cure cancer; Shigru (Moringa oleifera Lam.) is one of the most important drugs having anthraquinones, flavonoids, sitosterol, tannins, glycosides which possess the anticancer property. According to Bhavprakash Shigru is useful in the treatment of Apachi, Gulma and Ganda. Raj Nighantu mentioned Shigru as Mukhjadyahar (oral disorder). This study focuses on anticancer property of Shigru leaves on different cell lines of oral cancer by in vitro study.

Risk Factors and Angiographic Profile in Young Individuals with Acute ST-Elevation Myocardial Infarction (STEMI)

Coronary artery disease (CAD) represents the leading cause of death in adults and Myocardial infarction (MI) is the lethal manifestation of that. Although males and females beyond certain age are prone to CAD, young men and/or women also suffer from MI. Apart from the rare case reports of non-athermatous coronary artery disease including hyper-coagulable states, spontaneous dissections and/or substance abuse in young MI, the prevalence of conventional risk factors are on rise in young adults and children. The protection offered by young age has been overshadowed by the increased prevalence of these risk factors. To evaluate the prevalence of such conventional risk factors and angiographic pattern in young MI, we did an observational, retrospective study at our tertiary care center. It was observed that one-fourth of young MI had no conventional risk factors and among the rest, obesity (48%) was most common, followed by diabetes mellitus (DM) (32%), Hypertension (29.5%), smoking (15.5%), alcoholism (11%), and a family history of premature CAD (3%). Among the participants, 35.5%, 22.5%, 12%, 4%, and 1% of patients had one, two, three, four, and five risk factors, respectively. On angiography, Left Anterior Descending (LAD) was the most commonly diseased coronary artery (77%) followed by Right Coronary Artery (RCA) (30.5%) and Left Circumflex (LCx) (29.5%). Single-vessel disease (SVD) (69.5%) was the most frequent observation on CAG, whereas 24% and 6.5% of patients had double-vessel and triple-vessel disease (DVD, TVD), respectively.

Determination of causes of adult deaths using minimally invasive tissue sampling in Gandaki province of Nepal: a multicenter hospital-based study

BackgroundMinimally Invasive Tissue Sampling (MITS) has been successfully used to establish the cause of death in low- and middle-income countries, mostly in stillbirths and neonates. The objective of this study was to determine the causes of death among adults using MITS in the Gandaki province of Nepal and to find out the contribution of MITS to identify the causes of death.MethodsA multicentric hospital-based pilot study was conducted to enroll 100 cases of adult deaths. The specimens of cerebrospinal fluid, blood, brain, lungs, and liver tissue were collected utilizing MITS. These specimens underwent standard histopathological, serological, and microbiological analyses. The findings from MITS, and if available, clinical records and forensic autopsy findings were compiled and the cause of death panel identified the causes of death. The final cause of death allocated to each case was based on the WHO International Medical Certificate of Death.ResultsAmong a total of 100 cases enrolled during the study period, infectious cause attributed to the immediate cause of death in 77 (77%), cardiovascular in 10 (10%), neurological in 8 (8%), malignancy in two (2%), and gastrointestinal and hepatobiliary cause in one (1%) case. The mean age of the cases was 50.8 ± 15.9 years and 76 (76%) were males. MITS established the cause of death in the causal chain of events in 81(81%) cases and identified the cause of death significantly more with infectious than non-infectious causes (p < 0.001).ConclusionsMITS was useful in establishing the cause of death in the majority of adult deaths and the most common cause was infectious disease. Our findings suggest that MITS can be a valuable and alternative tool for mortality surveillance in low-resource settings, where complete diagnostic autopsies are less accepted or less prioritized.